P16 Hypermethylation Predicts Surgical Outcome Following Curative Resection of Mid/Distal Bile Duct Cancer

[1]  J. Herman,et al.  Promoter CpG island methylation markers in colorectal cancer: the road ahead. , 2012, Epigenomics.

[2]  S. Clark,et al.  Epigenetics in prostate cancer: biologic and clinical relevance. , 2011, European urology.

[3]  R. Shaw,et al.  RE: P16 INK41 promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age dependent manner. Su et al. Oral Oncology 46 (2010) 734-739. , 2011, Oral oncology.

[4]  H. El‐Serag,et al.  Risk factors for cholangiocarcinoma , 2011, Hepatology.

[5]  P. Cairns,et al.  Epigenetics of kidney cancer and bladder cancer. , 2011, Epigenomics.

[6]  Tsung-Yun Liu,et al.  p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner. , 2010, Oral oncology.

[7]  A. Kulkarni,et al.  Current research in perineural invasion of cholangiocarcinoma , 2010, Journal of experimental & clinical cancer research : CR.

[8]  Tsuyoshi Saito,et al.  Aberrant p16INK4a methylation is a frequent event in colorectal cancers: prognostic value and relation to mRNA expression and immunoreactivity , 2010, Journal of Cancer Research and Clinical Oncology.

[9]  H. Isomoto.  Epigenetic alterations associated with cholangiocarcinoma (review). , 2009, Oncology reports.

[10]  Seung Woo Park,et al.  The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection , 2009, Journal of surgical oncology.

[11]  H. Kırımlıoğlu,et al.  The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis. , 2009, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[12]  Jun Yu,et al.  Promoter methylation of the Wnt/β‐catenin signaling antagonist Dkk‐3 is associated with poor survival in gastric cancer , 2008, Cancer.

[13]  Kamran Ayub,et al.  Cell Proliferation, Cell Cycle Abnormalities, and Cancer Outcome in Patients with Barrett's Esophagus: A Long-term Prospective Study , 2008, Clinical Cancer Research.

[14]  Shuji Ogino,et al.  CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer , 2008, Gut.

[15]  B. Wiedenmann,et al.  Inducible re-expression of p16 in an orthotopic mouse model of pancreatic cancer inhibits lymphangiogenesis and lymphatic metastasis , 2008, British Journal of Cancer.

[16]  T. Hirano,et al.  The genetic differences between gallbladder and bile duct cancer cell lines. , 2006, Oncology reports.

[17]  S. Tomoyasu,et al.  Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group. , 2006, Leukemia research.

[18]  J. Herman,et al.  Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma , 2005, Modern Pathology.

[19]  T. Sugai,et al.  Promoter hypermethylation of DAP‐kinase is associated with poor survival in primary biliary tract carcinoma patients , 2004, Cancer science.

[20]  K A Baggerly,et al.  Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. , 2003, BioTechniques.

[21]  Peter Nürnberg,et al.  Evaluation of a potential epigenetic biomarker by quantitative methyl‐single nucleotide polymorphism analysis , 2002, Electrophoresis.

[22]  Hwoong-Yong Jung,et al.  Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma. , 2002, The American journal of pathology.

[23]  D. Cooper,et al.  DNA methylation and CpG suppression. , 1985, Cell differentiation.

[24]  M. Guida,et al.  Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions. , 2009, European journal of gynaecological oncology.

[25]  최진섭,et al.  The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection , 2009 .

[26]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.